Keep the vial upright, away from light, and discard any solution that becomes cloudy, discolored, or develops particles
Embodiment 2 [0048] Example 2: Synthesis of Intermediate I [0049] [0050] R 1 =Fmoc, R 3 =Fmoc [0051] Weigh 50.00g Fmoc-L-His(Fmoc)-OH into 500ml dichloromethane, stir, add 21.55g DIPEA (2.00eq) to the reaction flask, stir to dissolve, and add 14.21g DIC (1.35g) to the reaction flask in turn eq), 15.21g HOBt (1.35eq), 19.58g 2-aminoisobutyric acid tert-butyl ester hydrochloride (1.20eq), stirred for 6 hours, the reaction was complete, the reaction solution was concentrated, the residue was dissolved in 300ml EA, and the organic phase was dissolved in 300ml Washed twice with purified water, washed once with 300ml of saturated aqueous sodium chloride solution, separated, collected the organic phase, concentrated the organic phase to 100g, controlled the temperature to 0-10C, added the concentrated dropwise to 750ml of petroleum ether for crystallization, and finished the dropwise addition After that, the mixture was kept at 0-10C and stirred for 30 minutes, filtered, and the fil
Emerging therapies targeting bilirubin pathways Recent advancements in molecular and pharmacological research have introduced novel therapeutic strategies for modulating bilirubin metabolism, offering potential clinical applications in hepatobiliary disorders
7 Les Accompagnateurs de Jene agrs FFJR partagent des informations concernant le jene, lalimentation et lhygine de vie en restant dans le domaine du bien-tre, et nutilisant pas de vocabulaire mdical (soigner, thrapeutique, )
Tirzepatide: Which Is Better for Weight Loss
